Deutsche Bank Downgrades Marvell (MRVL) to Hold, Weakness to Continue

Credit Suisse Downgrades Marvell (MRVL) to Neutral

October 19, 2012 1:14 PM EDT

Earlier, Credit Suisse downgraded Marvell (NASDAQ: MRVL) from Outperform to Neutral with a price target of $8.50 (from $18.00).

Credit Suisse is one of more than a half a dozen firms that downgraded the stock today after lower third quarter guidance and the CFO... More

Notable Analyst Rating Changes 10/19: (ISRG) (ABT) (NOK) Upgraded; (NVDA) (JNS) (GOOG) Downgraded

October 19, 2012 10:42 AM EDT
UPGRADES
BofA/Merrill Lynch boosts Intuitive Surgical (Nasdaq: ISRG) from Neutral to Buy.

Wells Fargo upgrades Abbott Labs (NYSE: ABT) from Market Perform to Outperform, moving its valuation range from $72 to $74 down to $71 to $74.... More

Pre-Open Movers 10/19: (RVBD) (CALL) (SNDK) Higher; (CBLI) (CMG) (ATHN) Lower (more...)

October 19, 2012 9:34 AM EDT

Cleveland BioLabs, Inc. (Nasdaq: CBLI) 20% LOWER; announced today that it has priced an underwritten public offering of 7,500,000 units at a price to the public of $2.00 per unit, resulting in gross proceeds of $15.0 million. Each unit consists of one share of common stock and one warrant to purchase 0.5 shares of common stock at an exercise price of $3.00 per whole share.

Chipotle Mexican Grill (NYSE: CMG) 12% LOWER; reported Q3 EPS of $2.27, $0.03 worse than the analyst estimate of $2.30. Revenue for the quarter came in at $700.5 million versus... More

Another Analyst Downgrade for Marvell (MRVL)

October 19, 2012 7:42 AM EDT

Jefferies downgraded Marvell (NASDAQ: MRVL) from Buy to Hold with a revised price target of $9.00 (from $15.00).

Marvel recently announced the departure of its CFO, Clyde Hosein, who left the company to pursue other opportunities. Marvell also announced recently that it expects lower... More

Lazard Capital Downgrades Marvell (MRVL) to Neutral

October 19, 2012 7:39 AM EDT

Lazard Capital downgraded Marvell (NASDAQ: MRVL) from Buy to Neutral following lower third quarter guidance and CFO departure.

For an analyst ratings summary and ratings history on Marvell click here. For more ratings news on Marvell click here.

Shares of Marvell closed at $8.83 yesterday, with a 52 week range of $8.67-$16.86.... More

CLSA Downgrades Marvell (MRVL) to Underperform

October 19, 2012 7:16 AM EDT

CLSA downgraded Marvell (NASDAQ: MRVL) from Outperform to Underperform with a price target of $8.40 (from $13.00) after lower third quarter guidance and CFO departure.

For an analyst ratings summary and ratings history on Marvell... More

FBR Capital Downgrades Marvellf (MRVL) to Market Perform

October 19, 2012 7:15 AM EDT

FBR Capital downgraded Marvellf (NASDAQ: MRVL) from Outperform to Market Perform with a price target of $9.50 (from $12.50) after lower third quarter guidance and CFO departure.

For an analyst ratings summary and ratings history on Marvellf... More

JPMorgan Downgrades Marvell (MRVL) to Neutral

October 19, 2012 7:14 AM EDT

JPMorgan downgraded Marvell (NASDAQ: MRVL) from Overweight to Neutral with a price target of $10.00 (from $16.00) after lower third quarter guidance and CFO departure.

For an analyst ratings summary and ratings history on Marvell... More

BofA/Merrill Lynch Downgrades Marvell (MRVL) to Underperform

October 19, 2012 6:50 AM EDT

BofA/Merrill Lynch downgraded Marvell (NASDAQ: MRVL) from Neutral to Underperform following lower third quarter outlook and CFO departure.

For an analyst ratings summary and ratings history on Marvell click here.... More

After-Hours Movers 10/18: (RVBD) (NCR) (SNDK) Higher; (CMG) (MRVL) (ETFC) Lower (more...)

October 18, 2012 5:56 PM EDT

Chipotle Mexican Grill (NYSE: CMG) 11% LOWER; reported Q3 EPS of $2.27, $0.03 worse than the analyst estimate of $2.30. Revenue for the quarter came in at $700.5 million versus the consensus estimate of $702.22 million.

Isis Pharmaceuticals (NASDAQ: ISIS) 11% HIGHER; resumes trading up 11 percent to following FDA panel backing of KYNAMRO.

Marvell (NASDAQ: MRVL) 10% LOWER; expects net revenue for the third quarter of fiscal 2013 will be in the range of $765 million to $785 million, compared with prior... More

Marvell (MRVL) CFO Hosein to Resign

October 18, 2012 4:23 PM EDT

In addition to cutting its third quarter outlook, Marvell (NASDAQ: MRVL) announced that Clyde Hosein has resigned as chief financial officer to pursue other opportunities.

Brad Feller, vice president and corporate controller, will serve as interim chief financial officer during a search... More

Marvell (MRVL) Cuts Q3 Revs Outlook

October 18, 2012 4:05 PM EDT

Marvell (NASDAQ: MRVL), a global leader in integrated silicon solutions, today updated its financial outlook for the third quarter of fiscal 2013, ending October 27, 2012.

Marvell now expects net revenue for the third quarter of fiscal 2013 will be in the range of $765 million to $785 million,... More